Cognitive screening in Multiple Sclerosis: the Five-Point Test as a substitute for the PASAT in measuring executive function

Sascha Hansen, Jana Muenssinger, Simona Kronhofmann, S. Lautenbacher, P. Oschmann, Philipp M. Keune
{"title":"Cognitive screening in Multiple Sclerosis: the Five-Point Test as a substitute for the PASAT in measuring executive function","authors":"Sascha Hansen, Jana Muenssinger, Simona Kronhofmann, S. Lautenbacher, P. Oschmann, Philipp M. Keune","doi":"10.1080/13854046.2016.1241894","DOIUrl":null,"url":null,"abstract":"Abstract Objective: The Paced Auditory Serial Addition Test (PASAT) is frequently employed to measure executive functions in patients with Multiple Sclerosis (MS). In the past, the PASAT has often been criticized because of its stressful and demanding requirements. Continuous utilization might also reduce its validity. The Five-Point Test (FPT) by Regard, Strauss, and Knapp ((1982) Children’s production on verbal and non-verbal fluency tasks. Perceptual and Motor Skills, 55, 839–844.) is a short test of figural fluency which might serve as a substitute.Method: 116 patients diagnosed with MS were tested with a short version of the Brief Repeatable Battery (BRB) by Rao and the Cognitive Function Study Group of the National Multiple Sclerosis Society including the PASAT, as well as the FPT. A factor analysis was computed and the frequency of cognitive impairment was calculated for both the original short version of the BRB and the alternative version (involving the FPT).Results: In the factor analysis, PASAT and FPT loaded highest on the same factor (two factors were extracted). The estimation of the frequency of cognitive impairment showed that replacing the PASAT with the FPT did not considerably alter the proportion of patients identified as cognitively impaired.Conclusions: The FPT proved to be a viable alternative to the PASAT in this study. It may be recommended as a possible replacement in neuropsychological screening of MS-patients with the advantage of avoiding the indicated limitations of the PASAT.","PeriodicalId":197334,"journal":{"name":"The Clinical neuropsychologist","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"15","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Clinical neuropsychologist","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/13854046.2016.1241894","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 15

Abstract

Abstract Objective: The Paced Auditory Serial Addition Test (PASAT) is frequently employed to measure executive functions in patients with Multiple Sclerosis (MS). In the past, the PASAT has often been criticized because of its stressful and demanding requirements. Continuous utilization might also reduce its validity. The Five-Point Test (FPT) by Regard, Strauss, and Knapp ((1982) Children’s production on verbal and non-verbal fluency tasks. Perceptual and Motor Skills, 55, 839–844.) is a short test of figural fluency which might serve as a substitute.Method: 116 patients diagnosed with MS were tested with a short version of the Brief Repeatable Battery (BRB) by Rao and the Cognitive Function Study Group of the National Multiple Sclerosis Society including the PASAT, as well as the FPT. A factor analysis was computed and the frequency of cognitive impairment was calculated for both the original short version of the BRB and the alternative version (involving the FPT).Results: In the factor analysis, PASAT and FPT loaded highest on the same factor (two factors were extracted). The estimation of the frequency of cognitive impairment showed that replacing the PASAT with the FPT did not considerably alter the proportion of patients identified as cognitively impaired.Conclusions: The FPT proved to be a viable alternative to the PASAT in this study. It may be recommended as a possible replacement in neuropsychological screening of MS-patients with the advantage of avoiding the indicated limitations of the PASAT.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多发性硬化症的认知筛查:五点测试替代PASAT测量执行功能
摘要目的:节奏性听觉序列加法测验(PASAT)常用于测量多发性硬化症(MS)患者的执行功能。在过去,PASAT经常受到批评,因为它的压力和苛刻的要求。持续使用也可能降低其有效性。Regard、Strauss和Knapp(1982)的五点测验(FPT):儿童在语言和非语言流畅性任务上的生产。知觉和运动技能,55,839 - 844)是一个简短的图形流畅性测试,可以作为替代。方法:由Rao和美国国家多发性硬化症学会认知功能研究组(包括PASAT)以及FPT,对116例诊断为MS的患者进行简短可重复电池(BRB)测试。计算了因子分析,并计算了原始短版本的BRB和替代版本(包括FPT)的认知障碍频率。结果:在因子分析中,PASAT和FPT在同一因子上的负荷最高(提取两个因子)。对认知障碍频率的估计表明,用FPT代替PASAT并没有显著改变认知障碍患者的比例。结论:在本研究中,FPT被证明是PASAT的可行替代方案。它可能被推荐作为ms患者神经心理筛查的可能替代方法,其优点是避免了PASAT的指示局限性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Gender and Autism Program: A novel clinical service model for gender-diverse/transgender autistic youth and young adults. Neuropsychological functioning of pediatric patients with long COVID. A roadmap for psychometrist training: Moving from condemnation and confusion to cooperation and collaborationA Neuropsychologist’s Guide to Training Psychometrists: Promoting Competence in Psychological Testing. edited by Ghilain, C. S. New York: Routledge. (2021), ­160 pages. ISBN: 036756498X. $140.00 (hbk) Introductory editorial to the special issue: Assessment and diagnosis of autism spectrum disorder (ASD) and related clinical decision making in neuropsychological practice Affirmative neuropsychological practice with transgender and gender diverse individuals and communities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1